P Meyrat

Summary

Country: Switzerland

Publications

  1. doi Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months
    P Meyrat
    Private Practice for Gastroenterology and Hepatology, Solothurn, Switzerland
    Aliment Pharmacol Ther 36:1084-93. 2012

Collaborators

Detail Information

Publications1

  1. doi Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months
    P Meyrat
    Private Practice for Gastroenterology and Hepatology, Solothurn, Switzerland
    Aliment Pharmacol Ther 36:1084-93. 2012
    ..While rifaximin was able to improve symptoms in patients with irritable bowel syndrome (IBS) in phase III trials, these results are yet to be repeated in phase IV studies...